Innovations in multi-parameter cell based assays, following 20 years of R&D, to develop fundamental new ways to measure platelet function in clinical trials, diagnostics and research.
Revolutionising blood analysis
Our technology uses multiparameter platelet function analysis to transform:
Precision assays to determine the Health impacts of drug efficacy and off-target effects, providing the Clarity needed to treat patients and derisk drug development.
Our technologies in a nutshell
HaemAnalytica’s next generation technologies set a new standard for stratification of patients and the assessment of on- and off-target drug effects on bleeding and thrombosis.
Multi-parameter assays and AI-based phenotyping, enabling insightful platelet analysis to de-risk clinical trials and enhance drug development.
